U.S., Sept. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07161843) titled 'Use of QRX-3 for Acute Tubular Necrosis Type of Renal Failure in Hospitalized Patients ( QRX-3 in ARF)' on April 10.
Brief Summary: Use of QRX-3 in hospitalized patients with pediatric and adult patients with acute tubular necrosis renal failure
Study Start Date: Aug. 30
Study Type: INTERVENTIONAL
Condition:
Acute Renal Failure (ARF)
Acute Tubular Necrosis
Intervention:
DRUG: QRX-3
Combination of QRX-3 with standard therapy will be given to one arm in trial , another arm will receive placebo
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Ebima Clifford Okundaye
Information provided by (Responsible Party): Ebima Clifford ...